vs
Side-by-side financial comparison of Ouster, Inc. (OUST) and Vanda Pharmaceuticals Inc. (VNDA). Click either name above to swap in a different company.
Ouster, Inc. is the larger business by last-quarter revenue ($62.2M vs $57.2M, roughly 1.1× Vanda Pharmaceuticals Inc.). On growth, Ouster, Inc. posted the faster year-over-year revenue change (106.6% vs 7.6%). Vanda Pharmaceuticals Inc. produced more free cash flow last quarter ($-29.5M vs $-37.2M). Over the past eight quarters, Ouster, Inc.'s revenue compounded faster (54.8% CAGR vs 9.8%).
Ouster, Inc. is an American lidar technology company headquartered in San Francisco, California. It builds high-resolution, digital 3D lidar sensors for use in autonomous vehicles, industrial, robotics, drones, mapping, defense, and security systems.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system disorders. Its key marketed products cover indications including sleep-wake cycle disturbances and schizophrenia, with core operations and primary sales markets concentrated in North America, catering to patient groups with significant unmet medical needs.
OUST vs VNDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.2M | $57.2M |
| Net Profit | — | $-141.2M |
| Gross Margin | 60.2% | — |
| Operating Margin | 1.5% | -70.5% |
| Net Margin | — | -246.8% |
| Revenue YoY | 106.6% | 7.6% |
| Net Profit YoY | — | -2774.3% |
| EPS (diluted) | $0.10 | $-2.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.2M | $57.2M | ||
| Q3 25 | $39.5M | $56.3M | ||
| Q2 25 | $35.0M | $52.6M | ||
| Q1 25 | $32.6M | $50.0M | ||
| Q4 24 | $30.1M | $53.2M | ||
| Q3 24 | $28.1M | $47.7M | ||
| Q2 24 | $27.0M | $50.5M | ||
| Q1 24 | $25.9M | $47.5M |
| Q4 25 | — | $-141.2M | ||
| Q3 25 | $-21.7M | $-22.6M | ||
| Q2 25 | $-20.6M | $-27.2M | ||
| Q1 25 | $-22.0M | $-29.5M | ||
| Q4 24 | — | $-4.9M | ||
| Q3 24 | $-25.6M | $-5.3M | ||
| Q2 24 | $-23.9M | $-4.5M | ||
| Q1 24 | $-23.8M | $-4.1M |
| Q4 25 | 60.2% | — | ||
| Q3 25 | 42.1% | — | ||
| Q2 25 | 45.2% | — | ||
| Q1 25 | 41.3% | — | ||
| Q4 24 | 43.8% | — | ||
| Q3 24 | 38.3% | — | ||
| Q2 24 | 33.7% | — | ||
| Q1 24 | 28.6% | — |
| Q4 25 | 1.5% | -70.5% | ||
| Q3 25 | -61.4% | -55.6% | ||
| Q2 25 | -76.5% | -73.2% | ||
| Q1 25 | -73.0% | -82.0% | ||
| Q4 24 | -85.1% | -19.3% | ||
| Q3 24 | -98.0% | -23.1% | ||
| Q2 24 | -93.6% | -20.1% | ||
| Q1 24 | -99.5% | -19.5% |
| Q4 25 | — | -246.8% | ||
| Q3 25 | -55.0% | -40.1% | ||
| Q2 25 | -58.8% | -51.7% | ||
| Q1 25 | -67.5% | -58.9% | ||
| Q4 24 | — | -9.2% | ||
| Q3 24 | -91.1% | -11.2% | ||
| Q2 24 | -88.4% | -9.0% | ||
| Q1 24 | -91.9% | -8.7% |
| Q4 25 | $0.10 | $-2.40 | ||
| Q3 25 | $-0.37 | $-0.38 | ||
| Q2 25 | $-0.38 | $-0.46 | ||
| Q1 25 | $-0.42 | $-0.50 | ||
| Q4 24 | $-0.46 | $-0.09 | ||
| Q3 24 | $-0.54 | $-0.09 | ||
| Q2 24 | $-0.53 | $-0.08 | ||
| Q1 24 | $-0.55 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $208.6M | $84.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $261.7M | $327.2M |
| Total Assets | $349.5M | $488.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $208.6M | $84.9M | ||
| Q3 25 | $244.5M | $70.0M | ||
| Q2 25 | $226.5M | $81.0M | ||
| Q1 25 | $168.2M | $111.8M | ||
| Q4 24 | $172.0M | $102.3M | ||
| Q3 24 | $151.4M | $100.5M | ||
| Q2 24 | $184.2M | $103.0M | ||
| Q1 24 | $187.8M | $125.2M |
| Q4 25 | $261.7M | $327.2M | ||
| Q3 25 | $247.4M | $466.0M | ||
| Q2 25 | $221.0M | $486.3M | ||
| Q1 25 | $167.9M | $511.4M | ||
| Q4 24 | $180.9M | $538.5M | ||
| Q3 24 | $171.7M | $541.2M | ||
| Q2 24 | $170.6M | $542.5M | ||
| Q1 24 | $167.2M | $544.0M |
| Q4 25 | $349.5M | $488.9M | ||
| Q3 25 | $353.8M | $601.1M | ||
| Q2 25 | $321.8M | $624.7M | ||
| Q1 25 | $268.6M | $631.9M | ||
| Q4 24 | $276.1M | $656.2M | ||
| Q3 24 | $255.2M | $645.1M | ||
| Q2 24 | $309.9M | $651.4M | ||
| Q1 24 | $317.7M | $652.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.4M | $-29.4M |
| Free Cash FlowOCF − Capex | $-37.2M | $-29.5M |
| FCF MarginFCF / Revenue | -59.8% | -51.6% |
| Capex IntensityCapex / Revenue | 35.0% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-64.8M | $-110.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-15.4M | $-29.4M | ||
| Q3 25 | $-18.3M | $-31.6M | ||
| Q2 25 | $-1.3M | $-15.3M | ||
| Q1 25 | $-4.9M | $-33.1M | ||
| Q4 24 | $-2.6M | $-1.8M | ||
| Q3 24 | $-3.8M | $-14.6M | ||
| Q2 24 | $-21.6M | $-6.9M | ||
| Q1 24 | $-5.7M | $7.6M |
| Q4 25 | $-37.2M | $-29.5M | ||
| Q3 25 | $-20.0M | $-31.8M | ||
| Q2 25 | $-2.2M | $-15.6M | ||
| Q1 25 | $-5.4M | $-33.6M | ||
| Q4 24 | $-4.0M | $-2.0M | ||
| Q3 24 | $-4.3M | $-14.7M | ||
| Q2 24 | $-22.0M | $-7.0M | ||
| Q1 24 | $-7.1M | $7.6M |
| Q4 25 | -59.8% | -51.6% | ||
| Q3 25 | -50.7% | -56.5% | ||
| Q2 25 | -6.3% | -29.6% | ||
| Q1 25 | -16.6% | -67.1% | ||
| Q4 24 | -13.3% | -3.8% | ||
| Q3 24 | -15.4% | -30.9% | ||
| Q2 24 | -81.5% | -13.9% | ||
| Q1 24 | -27.4% | 15.9% |
| Q4 25 | 35.0% | 0.2% | ||
| Q3 25 | 4.3% | 0.3% | ||
| Q2 25 | 2.5% | 0.6% | ||
| Q1 25 | 1.7% | 0.9% | ||
| Q4 24 | 4.8% | 0.4% | ||
| Q3 24 | 2.0% | 0.3% | ||
| Q2 24 | 1.3% | 0.2% | ||
| Q1 24 | 5.3% | 0.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OUST
Segment breakdown not available.
VNDA
| Fanapt | $33.2M | 58% |
| Hetlioz | $16.4M | 29% |
| PONVORY | $7.6M | 13% |
